The World Stroke Organization is the only global body solely focused on stroke. With around 3500 individual and 100society members spanning every global region, we represent over 55,000 stroke specialists in clinical, research and community settings.
Care Directions
Advancing Recovery. Protecting Access to Rehabilitation
Alnylam
Alnylam has led the translation of RNA interference into a new class of approved and investigational medicines for transthyretin amyloidosis (TTR), rare, cardiovascular, metabolic, neurologic and other diseases. Learn more: www.alnylam.com. | Since its founding, Alnylam has led the translation of RNA interference (RNAi) into a new class of approved and investigational medicines for rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics are a clinically validated approach for the treatment of rare diseases with unmet medical need and prevalent diseases. Alnylam is headquartered in Cambridge, MA. For more information, please visit www.alnylam.com.
Access TeleCare
Access TeleCare is the standard bearer of clinical excellence in acute specialty telemedicine, providing high-quality care for patients in 1 out of 5 U.S. hospitals. Since it’s founding in 2004, the company has delivered care in over 8 million patient encounters across multiple specialty service lines, including behavioral health, neurology, hospitalist medicine, pulmonary and critical care, maternal-fetal medicine, infectious disease, cardiology, and nephrology. The virtual care provided by Access TeleCare is crucial in ensuring timely and high-quality healthcare coverage across a virtual catchment area of more than 65 percent of the U.S. population, representing a total population of over 216 million Americans, many of whom live in medically underserved or vulnerable areas. As the first and longest-standing telemedicine organization to receive The Joint Commission’s Gold Seal of Approval in 2006, Access TeleCare is leading the way to a better healthcare delivery system with clinically excellent tech-enabled services. | Access TeleCare is the standard bearer of clinical excellence in acute specialty telemedicine, providing high-quality care for patients in 1 out of 5 U.S. hospitals. Over the last 20 years, the company has delivered care in over 7 million patient encounters across multiple specialty service lines including behavioral health, neurology, hospitalist medicine, pulmonary and critical care, maternal-fetal medicine, infectious disease, cardiology, and nephrology. The virtual care provided by Access TeleCare is crucial in ensuring timely and high-quality healthcare coverage across a virtual catchment area of more than 65 percent of the U.S. population, representing a total population of over 216 million Americans, many of whom live in medically underserved or vulnerable areas. As the first and longest-standing telemedicine organization to receive The Joint Commission’s Gold Seal of Approval in 2006, Access TeleCare is leading the way to a better healthcare delivery system with clinically excellent tech-enabled services. | Access TeleCare is a nationwide leader in the field of telemedicine. Our specialties include behavioral health, cardiology, hospitalist, infectious disease, neurology, nephrology, pulmonary/critical care, maternal-fetal medicine, and cardiac arrest. | Access TeleCare is the standard bearer of clinical excellence in acute specialty telemedicine, providing high-quality care for patients in 1 out of 5 U.S. hospitals. Over the last 20 years, the company has delivered care in over 7 million patient encounters across multiple specialty service lines.